CAESAREA, Israel, Nov. 19, 2024 /PRNewswire/ — Epitomee Medical Ltd. (TASE: EPIT) announces that significant results from its RESET study on a novel oral hydrogel capsule for weight loss were presented at ObesityWeek® 2024. The prestigious event, organized by The Obesity Society (TOS),…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.